MYH rs3219476 and rs3219472 polymorphisms and risk of cholangiocarcinoma

Molecular Medicine Reports

Volumn 7, Issue 1, 2013, Pages 347-351

  You, Si Hong ^a   Wang, Xiang ^a   Huang, Shu ^a   Wang, Min ^a   Ji, Guo Zhong ^a   Xia, Jin Rong ^b   Fan, Zhi Ning ^a  

^a THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

Cholangiocarcinoma; MutY homolog; Polymorphism

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CASE-CONTROL STUDIES; CHOLANGIOCARCINOMA; DNA GLYCOSYLASES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; SEQUENCE ANALYSIS, DNA;

EID: 84873871581     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1175     Document Type: Article

References (24)

1. Isomoto H: Epigenetic alterations associated with cholangiocarcinoma (Review). Oncol Rep 22: 227-232, 2009.
2. Petrowsky H and Hong JC: Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation. Transplant Proc 41: 4023-4035, 2009.
3. Valle J, Wasan H, Palmer DH, etal: Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med362: 1273-1281, 2010.
4. Gatto M, Bragazzi MC, Semeraro R, etal: Cholangiocarcinoma: update and future perspectives. Dig Liver Dis 42: 253-260, 2010.
5. Shen FZ, Zhang BY, Feng YJ, etal: Current research in perineural invasion of cholangiocarcinoma. J Exp Clin Cancer Res 29: 24, 2010.
6. Meza-Junco J, Montano-Loza AJ, Ma M, Wong W, Sawyer MB and Bain VG: Cholangiocarcinoma: has there been any progress? Can J Gastroenterol 24: 52-57, 2010.
7. Ustundag Y and Bayraktar Y: Cholangiocarcinoma: a compact review of the literature. World J Gastroenterol 14: 6458-6466, 2008.
8. Shields PG and Harris CC: Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 18: 2309-2315, 2000.
9. Galvan A, Ioannidis JP and Dragani TA: Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer. Trends Genet 26: 132-141, 2010.
10. Martin SA, Hewish M, Lord CJ and Ashworth A: Genomic instability and the selection of treatments for cancer. J Pathol 220: 281-289, 2010.
11. Jiang J, Zhang X, Yang H and Wang W: Polymorphisms of DNA repair genes: ADPRT, XRCC1, and XPD and cancer risk in genetic epidemiology. Methods Mol Biol 471: 305-333, 2009.
12. David SS, O'Shea VL and Kundu S: Base-excision repair of oxidative DNA damage. Nature 447: 941-950, 2007.
13. Kasahara M, Osawa K, Yoshida K, etal: Association of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population. J Exp Clin Cancer Res27: 49, 2008.
14. Baudhuin LM, Roberts LR, Enders FT, etal: MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients. J Cancer Res Clin Oncol 132: 159-162, 2006.
15. Wang X, You SH, He W, et al: hOGG1 Ser326Cys polymorphisms and genetic susceptibility of cholangiocarcinomas. Journal of Medical Postgraduates 23: 1156-1159, 2010 (In Chinese).
16. You SH, Wang X, Huang S, Gao Y, Xia JR and Fan ZN: XRCC1 polymorphisms and genetic susceptibility of cholangiocarcinomas. Chinese Journal of Clinical Research 23: 1068-1072, 2010 (In Chinese).
17. Tsukino H, Hanaoka T, Otani T, etal: hOGG1 Ser326Cys polymorphism, interaction with environmental exposures, and gastric cancer risk in Japanese populations. Cancer Sci 95: 977-983, 2004.
18. Jones S, Emmerson P, Maynard J, etal: Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C-T:A mutations. Hum Mol Genet 11: 2961-2967, 2002.
19. Thyagarajan B, Lindgren B, Basu S, etal: Association between genetic variants in the base excision repair pathway and outcomes after hematopoietic cell transplantations. Biol Blood Marrow Transplant 16: 1084-1089, 2010.
20. Van Beers BE: Diagnosis of cholangiocarcinoma. HPB (Oxford) 10: 87-93, 2008.
21. Sieber OM, Lipton L, Crabtree M, etal: Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 348: 791-799, 2003.
22. Forsbring M, Vik ES, Dalhus B, etal: Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma. Carcinogenesis 30: 1147-1154, 2009.
23. Yang L, Zhou M, Zhu M, etal: Variation analysis of the MYH gene associated with sporadic colorectal cancer. Carcinogenesis, Teratogenesis and Mutagenesis 21: 435-438, 2009 (In Chinese).
24. Yang L, Zhu M, Chen SQ, etal: Research on MUTYH gene polymorphism associated with colorectal cancer. Shandong Medical Journal 49: 3-5, 2009 (In Chinese).